260 results
Page 5 of 13
8-K
EX-99.1
l5pnigpwrfy0j792rogi
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.2
8tcdos 8pguc5mfym6
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.1
wy7fmq 29b5
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
424B3
7vrslxnc40a6
2 Sep 20
Prospectus supplement
4:03pm
8-K
EX-99.1
0tgv2i
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
8-K
EX-10.1
rez fsrxum
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
os7zd76yxf49f
29 Jun 20
Prospectus supplement
12:00am
424B5
1moh9qg36i5
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
chrekj 8k
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
424B5
s2sr4z 5y9
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-10.1
jvmah
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-99.2
svqot3kotbqm
5 Mar 20
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.2
yb2066qdiwxi5p
18 Nov 19
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
6:21am